Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Klein

Showing results (1141-1150 of 1,374) with videos related to

Pageof 138
Sort By:
Environmental and Molecular Mutagenesis|February 28, 2013
Building on the past, shaping the future: the Environmental Mutagenesis and Genomics SocietyThomas E Wilson, David M DeMarini, Stephen D Dertinger, et al.
Journal of the American Society of Nephrology : JASN|August 1, 2009
Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuriaMichael L Merchant, Bruce A Perkins, Grzegorz M Boratyn, et al.
Endocrinology|March 30, 2022
Beta-Hydroxybutyrate Suppresses Hepatic Production of the Ghrelin Receptor Antagonist LEAP2Stephanie Holm, Anna S Husted, Louise J Skov, et al.
The Canadian Journal of Hospital Pharmacy|October 17, 2022
Trends in Use of Combination Antiretroviral Therapy and Treatment Response from 2000 to 2016 in the Canadian Observational Cohort (CANOC): A Longitudinal Cohort StudyAlison R McClean, Jason Trigg, Claudette Cardinal, et al.
Plos One|May 3, 2011
Functional genomics unique to week 20 post wounding in the deep cone/fat dome of the Duroc/Yorkshire porcine model of fibroproliferative scarringLoren H Engrav, Christopher K Tuggle, Kathleen F Kerr, et al.
HIV Clinical Trials|April 19, 2012
Relationship of chronic hepatitis C infection to rates of AIDS-defining illnesses in a Canadian cohort of HIV seropositive individuals receiving highly active antiretroviral therapyJ Raboud, A Anema, D Su, et al.
Plos One|January 7, 2014
Gender differences in clinical outcomes among HIV-positive individuals on antiretroviral therapy in Canada: a multisite cohort studyAngela Cescon, Sophie Patterson, Keith Chan, et al.
Journal of the International AIDS Society|April 11, 2018
Linkage and retention in HCV care for HIV-infected populations: early data from the DAA eraRachel Sacks-Davis, Joseph S Doyle, Andri Rauch, et al.
Plos One|July 13, 2017
Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitusKevin M Wheelock, Jian Cai, Helen C Looker, et al.
Trials|December 13, 2025
Fecal microbiota transplantation to reduce immune activation in ART-treated people with HIV with low CD4/CD8 ratio: protocol for the single-blind, randomized, placebo-controlled Gutsy study (CIHR/CTN PT038)Stéphane Isnard, Carolina A Berini, Seema Nair Parvathy, et al.
Pageof 138

Showing results (1141-1150 of 1,374) with videos related to

Sort By:
Pageof 138
Environmental and Molecular Mutagenesis|February 28, 2013
Building on the past, shaping the future: the Environmental Mutagenesis and Genomics SocietyThomas E Wilson, David M DeMarini, Stephen D Dertinger, et al.
Journal of the American Society of Nephrology : JASN|August 1, 2009
Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuriaMichael L Merchant, Bruce A Perkins, Grzegorz M Boratyn, et al.
Endocrinology|March 30, 2022
Beta-Hydroxybutyrate Suppresses Hepatic Production of the Ghrelin Receptor Antagonist LEAP2Stephanie Holm, Anna S Husted, Louise J Skov, et al.
The Canadian Journal of Hospital Pharmacy|October 17, 2022
Trends in Use of Combination Antiretroviral Therapy and Treatment Response from 2000 to 2016 in the Canadian Observational Cohort (CANOC): A Longitudinal Cohort StudyAlison R McClean, Jason Trigg, Claudette Cardinal, et al.
Plos One|May 3, 2011
Functional genomics unique to week 20 post wounding in the deep cone/fat dome of the Duroc/Yorkshire porcine model of fibroproliferative scarringLoren H Engrav, Christopher K Tuggle, Kathleen F Kerr, et al.
HIV Clinical Trials|April 19, 2012
Relationship of chronic hepatitis C infection to rates of AIDS-defining illnesses in a Canadian cohort of HIV seropositive individuals receiving highly active antiretroviral therapyJ Raboud, A Anema, D Su, et al.
Plos One|January 7, 2014
Gender differences in clinical outcomes among HIV-positive individuals on antiretroviral therapy in Canada: a multisite cohort studyAngela Cescon, Sophie Patterson, Keith Chan, et al.
Journal of the International AIDS Society|April 11, 2018
Linkage and retention in HCV care for HIV-infected populations: early data from the DAA eraRachel Sacks-Davis, Joseph S Doyle, Andri Rauch, et al.
Plos One|July 13, 2017
Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitusKevin M Wheelock, Jian Cai, Helen C Looker, et al.
Trials|December 13, 2025
Fecal microbiota transplantation to reduce immune activation in ART-treated people with HIV with low CD4/CD8 ratio: protocol for the single-blind, randomized, placebo-controlled Gutsy study (CIHR/CTN PT038)Stéphane Isnard, Carolina A Berini, Seema Nair Parvathy, et al.
Pageof 138